DANIEL LYNCH

Profile

First Name

: DANIEL

Middle Name

:

Last Name

: LYNCH

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
AVILA THERAPEUTICS INC
MICHAEL F. BIGHAM, BRUCE BOOTH, KATRINE BOSLEY, ROY R. LOBB, AMIR NASHAT, RAJ PAREKH, VICKI SATO, HENRY SKINNER
EXECUTIVE OFFICER, DIRECTOR
STROMEDIX INC
PETER BARRETT, MICHAEL GILMAN, RONALD HUNT, STEPHEN KRAUS, BRAD MARONI, SHEILA VIOLETTE
DIRECTOR
BLUEPRINT MEDICINES CORP
JEFFREY W. ALBERS, CHRISTINE BELLON, ALEXIS BORISY, STEPHEN KNIGHT, KYLE KUVALANKA, CHRISTOPH S. LENGAUER, NICHOLAS LYDON, NICK LYDON, DAVID SCHENKEIN, THILO SCHROEDER
DIRECTOR
RANA THERAPEUTICS, LLC
JEAN FRANCOIS FORMELA, BRIAN GALLAGHER, ROBERT PRENTISS, RONALD C. RENAUD, JR., JOSHUA RESNICK
DIRECTOR
PROCLARA BIOSCIENCES, INC.
KENNETH BUCKFIRE, VALERIE CALENDA, VALERIE CALENDA, PH.D., JOHN DEE, NICO DOSENBACH, RICHARD FISCHER, PH.D., RICHARD A. FISHER, PH.D., PAUL GOLDENHEIM, PAUL GOLDENHEIM, MD, FRANZ HEFTI, PH.D., HAMPUS HILLERSTROM, NICK LESCHLY, DAVID MICHELSON, M.D., VICKI SATO, HANS SCHOEPFLIN, MARK SKALETSKY, PETER SMEDVIG, JONATHAN SOLOMON, FRANCOIS VALENCONY
DIRECTOR
RANA THERAPEUTICS, INC.
ANN BARBIER, DANIELLA BECKMAN, PAUL BURGESS, PAULA CLOGHESSY, BRIAN FENTON, JEAN- FRANCOIS FORMELA, JEAN-FRANCOIS FORMELA, BRIAN GALLAGHER, MICHAEL HEARTLEIN, OWEN HUGHES, DANIEL S. LYNCH, THOMAS MCCAULEY, ROBERT J. MEYER, ROBERT M. PLENGE, RONALD RENAUD, JR., JOHN R. SCHROER, RICHARD WOOSTER
EXECUTIVE OFFICER, DIRECTOR
SPRINGWORKS THERAPEUTICS, LLC
CARL GORDON, PETER KEEN, FREDA LEWIS-HALL, M.D., DEVAL PATRICK, JEFF SCHWARTZ, STEPHEN SQUINTO, LARA SULLIVAN, M.D.
DIRECTOR
XILIO THERAPEUTICS, INC.
TIMOTHY CLACKSON, PAUL CLANCY, DANIEL CURRAN, PETER DUDEK, JOSEPH FARMER, DAVID GARDNER, DAVID GRAYZEL, ANDREW HACK, NANCY HONG, RACHEL HUMPHREY, MICHAEL ROSS, RENE RUSSO, ROBERT WEISSKOFF
DIRECTOR
2SEVENTY BIO, INC.
WILLIAM D. BAIRD, SARAH JS GLICKMAN, PHILIP GREGORY, NICOLA HEFFRON, RAMY IBRAHIM, NICK LESCHLY, MARCELA V. MAUS, WILLIAM R. SELLERS, DENICE TORRES
DIRECTOR
CARDURION PHARMACEUTICALS, INC.
NICHOLAS DOWNING, KEITH GOTTESDIENER, JEB KEIPER, ADAM KOPPEL, PETER LAWRENCE, EDWARD MATHERS, MICHAEL MENDELSOHN, KENNETH NOVACK, EVAN RACHLIN, EMMA REEVE, AMY SCHULMAN
DIRECTOR
GU CAPITAL LP
DARROL WHITE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-17
D
Link
POOLED INVESTMENT FUND 
 
 
Equity 
2026-01-23 
2024-07-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-10 
2022-03-31
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-17 
2021-02-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-23 
2021-01-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-20 
2017-09-01
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-18 
2017-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-22 
2016-11-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-01 
2015-07-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-17 
2014-11-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-10 
2014-01-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-06 
2011-01-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-01-24 
2010-07-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-16 
2009-07-31
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-07-16 
2009-05-14
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2009-04-29